HealthWhy the causes of poor mental health may share a common root The neat picture we once had about the causes of mental illness has turned out to be wrong, but we are building an understanding of a new single underlying factor Features
HealthNew drug donanemab slows cognitive decline in early Alzheimer's The experimental treatment donanemab is now the second antibody drug to slow cognitive decline in people with early stage Alzheimer’s disease, but questions remain about its real-world benefits and safety ¿ìè¶ÌÊÓÆµ